Vertex CF drug Kalydeco wins Aussie nod; GSK's Votrient gains full approval in EU;

@FiercePharma: Pfizer's vaccine hope Prevenar 13 wins new EU nod in adults. Will it translate into big sales? Report | Follow @FiercePharma

 @EricPFierce: Hikma ups doxycycline capacity as it brings production back at NJ plant that got FDA warning letter. ICYMI | Follow @EricPFierce

 @CarlyHFierce: Investors unhappy with plans from Russia's Pharmstandard to spin off OTC biz. May also buy Singapore-based Bever. Yesterday's story | Follow @CarlyHFierce

> Vertex Pharmaceuticals ($VRTX) won Australian approval for Kalydeco, its targeted drug for cystic fibrosis patients. Report

> GlaxoSmithKline's ($GSK) cancer drug Votrient saw its conditional approval status lifted in Europe, gaining full approval for marketing there. Release

> Prestige Brands, a maker of house-brand over-the-counter drugs, bought Australia's Care Pharmaceuticals to expand in the Asia-Pacific region. Report

> India's pharmaceutical exports are still growing, but at half the rate of two years ago, thanks to slowdowns in North America and Europe. Report

> A plaintiff's lawyer is pushing the FDA to release data on Johnson & Johnson's ($JNJ) antipsychotic drug Risperdal, the subject of a liabiity case that he is pursuing, to get around a judge's seal on the documents. Report

> Animal health company Dechra posted a 19% hike in fiscal year revenue but expects the current year to be a challenge. Report

> Sun Pharmaceuticals stock enjoyed a boost from good news about a competitor's strong sales of a generic antibiotic Sun also sells. Report

Medical Device News

@FierceMedDev: Myriad sues Ambry over Dx gene patents. News | Follow @FierceMedDev

 @MarkHFierce: Are CT scans overused in children? A new study concludes that they are, boosting cancer risks. ICYMI yesterday | Follow @MarkHFierce

@DamianFierce: NeuroPace has hauled in another $18M to get its anti-epilepsy implant through the FDA process. Story | Follow @DamianFierce

> Blockbusters and bloodlettings: A look at 2013's hot M&A start. Special report

> Abbott rides next-gen Xience stent into Japan. Article

> Diaper device designed to flag babies' health problems. More

Biotech News

@FierceBiotech: ChemAxon extends pharma software streak with Schrödinger deal. Article | Follow @FierceBiotech

 @JohnCFierce: When does pursuing a clinical study become unethical? Roche needs to review that question in the wake of aleglitazar fiasco. More | Follow @JohnCFierce

@RyanMFierce: Over 7 years EU & industry pumping €22.6B into R&D, €4.8B in pharma, to spur economic activity. Is it enough? Release | Follow @RyanMFierce

 @EmilyMFierce: 5 lessons from @FierceBiotech's rebooted LinkedIn group. Editor's corner | Follow @EmilyMFierce

> 'Breakthrough' ibrutinib NDA makes rapid arrival at FDA. News

> Biotech billionaire Kirk reaches for $125M score in Intrexon IPO. Story

Biomarkers News

> Urine-based genetic test triumphs in trial. More

> Measuring electrical frequencies in brain could indicate Huntington's disease. Report

> U.K. Dx zeroes in on bladder cancer biomarkers in urine odor. Story

> Measuring electrical frequencies in brain could indicate Huntington's disease. Article

> Biomarker could guide decision on follow-up breast cancer treatment. News

Drug Delivery News

> Acorda grabs liquid and patch pain treatments for $8M-plus. Article

> BDSI hauls in $20M for pain film, addiction gel. More

> Oramed launches oral insulin safety trial. Report

> European injectable drug delivery market poised to soar. News

> Antibiotic-delivery strategies could cut back on side effects. Story

And Finally... A Cornell University scientist is on a crusade to develop the perfect broccoli. Report